Lv5
1140 积分 2025-11-03 加入
SURMOUNT-2: new advances for treating obese type 2 diabetes with tirzepatide
18天前
已完结
IIH-Advance: A randomised clinical trial to determine the effects of weight loss, induced by a weight loss drug (Tirzepatide), in adults with active idiopathic intracranial hypertension
18天前
已完结
Tirzepatide and the risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials
1个月前
已完结
Luteolin as a novel therapeutic for diabetic kidney disease: Targeting the ADAM10-TREM2 pathway
1个月前
已完结
A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
3个月前
已关闭
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
3个月前
已完结
Glucagon-Like Peptide-1 Receptor Agonists and Decreased Subarachnoid Hemorrhage Risk in Patients With Intracranial Aneurysm
3个月前
已完结
Comment on “Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide in Diabetic CABG Patients: A Global Network Study of Propensity-Matched Patients”
5个月前
已完结
GLP-1RAs and tirzepatide may reduce heart failure risk in obese but not in non-obese patients with cardiovascular or renal disease: A systematic review and meta-analysis
5个月前
已完结
皖公网安备34019202002308
